Breaking News Instant updates and real-time market news.

HAS

Hasbro

$76.16

-0.46 (-0.60%)

, NEM

Newmont Mining

$34.86

0.63 (1.84%)

09:55
10/17/16
10/17
09:55
10/17/16
09:55

Early notable gainers among liquid option names on October 17th

Notable gainers among liquid option names this morning include Hasbro (HAS) $81.53 +5.35, Newmont (NEM) $35.08 +0.84, Diamond Drilling (DO) $17.53 +0.36, Mattel (MAT) $30.68 +0.58, and Public Service Enterprise Group (PEG) $41.64 +0.76.

HAS

Hasbro

$76.16

-0.46 (-0.60%)

NEM

Newmont Mining

$34.86

0.63 (1.84%)

DO

Diamond Offshore

$17.45

0.29 (1.69%)

MAT

Mattel

$30.10

0.12 (0.40%)

PEG

PSEG

$41.49

0.59 (1.44%)

  • 17

    Oct

  • 19

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 07

    Nov

HAS Hasbro
$76.16

-0.46 (-0.60%)

07/19/16
07/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Outperform from Underperform at CLSA with analyst Jeremy Scott saying the Chiptopia loyalty program is a highly compelling and engaging platform that re-energized its most loyal customers while providing a large-scale acquisition of customer data. 2. Hasbro (HAS) upgraded to Overweight from Neutral at Piper Jaffray with analyst Stephanie Wissink saying the recent pullback in shares provides an opportunity to buy for "holiday 2016 and full year 2017 drivers." 3. IDEX Corp. (IEX) upgraded to Buy from Neutral at Janney Capital with analyst Michael Gaugler saying the company's commentary that North American industrial end markets are showing signs of stabilization was probably more relevant than the second quarter results. 4. Ethan Allen (ETH) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Cristina Fernandez saying Ethan Allen has renewed sales momentum and sees several initiatives in the next few quarters that could sustain sales and drive shares higher. 5. Tesoro (TSO) upgraded to Buy from Neutral at Citi with analyst Faisel Khan saying the shares are trading at a significant discount to net asset value. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/10/16
PIPR
05/10/16
DOWNGRADE
Target $88
PIPR
Neutral
Hasbro downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Stephanie Wissink downgraded Hasbro to Neutral citing limited upside to her unchanged price target of $88. The analyst notes she's not a seller of the shares as she believes Hasbro deserves a premium multiple.
05/10/16
05/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wayfair (W) downgraded to Neutral at Citi by analyst Mark May, who said international investments and aggressive hiring are likely to limit EBITDA upside in 2016. 2. SolarCity (SCTY) downgraded to Neutral at BofA/Merrill by analyst Krish Sankar, who said the company's strategy to manage growth and costs, and long-term economic value creation has become increasingly unclear. He also said the cost strategy will be impacted by numerous factors including the policy environment, financing and execution risks. The company was also downgraded to Market Perform at Avondale. 3. Hasbro (HAS) downgraded to Neutral at Piper Jaffray with analyst Stephanie Wissink citing limited upside to her unchanged price target of $88. 4. Nike (NKE) resumed with a Market Perform at Wells Fargo by analyst Tom Nikic, who said the company's near-term financials "may prove to be fairly noisy" due to the upcoming Summer Olympics in Brazil. The analyst adds that Nike is facing a level of competition that it has not experienced in quite some time. 5. Sprouts Farmers Markets (SFM) downgraded to Sell at Goldman with analyst Stephen Grambling saying both thee consensus estimates and the valuation are overly optimistic. He said that increasing competition caused the company's comp growth to stall. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/16
PIPR
07/19/16
UPGRADE
Target $88
PIPR
Overweight
Hasbro upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Stephanie Wissink upgraded Hasbro to Overweight saying the recent pullback in shares provides an opportunity to buy for "holiday 2016 and full year 2017 drivers." Momentum should return to Hasbro business, led by girls and games in the second half of 2016, Wissink tells investors in a research note. The analyst keeps an $88 price target for the shares.
NEM Newmont Mining
$34.86

0.63 (1.84%)

06/02/16
JEFF
06/02/16
DOWNGRADE
Target $33
JEFF
Hold
Newmont Mining downgraded to Hold from Buy at Jefferies
Jefferies analyst Christopher LaFemina downgraded Newmont Mining to Hold citing valuation, near-term gold price risk, potential U.S. interest rate increase headwinds and a lack of positive catalysts. The analyst lowered his price target for the shares to $33 from $38.
08/02/16
SBSH
08/02/16
INITIATION
Target $51
SBSH
Buy
Newmont Mining initiated with a Buy at Citi
Citi analyst Alexander Hacking started Newmont Mining with a Buy rating and $51 price target.
08/09/16
MSCO
08/09/16
INITIATION
Target $41
MSCO
Equal Weight
Newmont Mining initiated with an Equal Weight at Morgan Stanley
Target $41.
10/17/16
LEHM
10/17/16
UPGRADE
Target $45
LEHM
Overweight
Newmont Mining upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Matthew Korn upgraded Newmont Mining to Overweight citing an "attractive" set of near-term catalysts around a higher dividend and the initiation of Ghana projects. The analyst keeps a $45 price target for the shares.
DO Diamond Offshore
$17.45

0.29 (1.69%)

09/20/16
09/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Betsy Graseck saying shares are trading at a 11 times Price/Earnings for a 3.5% yield, and is one of the "best values" in the S&P 1500 and the sector. 2. Tech Data (TECD) was upgraded to Buy from Hold at Stifel, to Buy from Underperform at CLSA, and to Buy from Neutral at BofA/Merrill. 3. AMD (AMD) upgraded to Market Perform from Underperform at Bernstein. 4. Diamond Offshore (DO) upgraded to Buy from Hold at Evercore ISI with analyst James West saying he believes the offshore rig market will bottom over the next 6-12 months and notes shares are down approximately 42% from its mid-July peak. 5. BHP Billiton (BHP) upgraded to Outperform from Neutral at Macquarie with analyst Alon Olsha citing an increase in coal/manganese forecasts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
GHSC
10/07/16
DOWNGRADE
GHSC
Neutral
Diamond Offshore downgraded to Neutral from Accumulate at Seaport Global
Seaport Global analyst Mark Brown downgraded Diamond Offshore to Neutral citing recent share strength and maintained its $17 price target.
10/17/16
LYON
10/17/16
UPGRADE
Target $17
LYON
Underperform
Diamond Offshore upgraded to Underperform from Sell at CLSA
CLSA analyst David Havens upgraded Diamond Offshore to Underperform given its peer-leading liquidity metrics and view that its cancellation risks are largely reflected in valuation. Havens maintained his $17 price target on Diamond Offshore shares.
09/21/16
GSCO
09/21/16
DOWNGRADE
GSCO
Sell
Diamond Offshore downgraded to Sell from Neutral at Goldman
Goldman analyst Waqar Syed downgraded Diamond Offshore to Sell and sees further downside to its $10 price target. The analyst said a significant number of Diamond's above market contracts are set to expire through 2020 and notes 3 key contracts make up 76% of 2018 estimated gross profits, and if one were to get canceled, EBITDA could correct sooner than forecast.
MAT Mattel
$30.10

0.12 (0.40%)

09/19/16
09/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. 2. Wells Fargo (WFC) upgraded to Outperform from Neutral at Baird analyst David George saying he believes the recent pullback is a buying opportunity. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Sam Pearlstein saying he believes the company's earnings can grow 20% per year through 2020. 4. U.S. Steel (X), AK Steel (AKS), and Olympic Steel (ZEUS) were upgraded to Sector Weight from Underweight at KeyBanc with analyst Ivan Marcuse saying the stocks at current levels better reflect the more competitive market conditions he expects in Q4 and 2017. 5. Mattel (MAT) upgraded to Buy from Neutral at Monness Crespi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
BMOC
10/03/16
NO CHANGE
Target $40
BMOC
Outperform
Mattel turnaround on track, says BMO Capital
BMO Capital analyst Gerrick Johnson attended last week's Dallas Fall Toy Preview and met with Mattel management in Los Angeles. The analyst said management seemed upbeat and confident that the company's business is on the right path towards recovery. Based on early holiday season and back-to-school channel checks, Johnson believes Mattel's business is good. Conversations with retailers and other toy companies have confirmed this, and his view is unchanged after meetings with management. The analyst said Mattel's turnaround is on track and reiterates his Outperform rating and $40 price target.
10/10/16
MKMP
10/10/16
UPGRADE
MKMP
Buy
Mattel upgraded to Buy from Neutral at MKM Partners
10/10/16
MKMP
10/10/16
UPGRADE
Target $36
MKMP
Buy
Mattel upgraded to Buy, risk/reward favorable at MKM Partners
As previously reported, MKM Partners upgraded Mattel to Buy from Neutral and maintained its $36 price target. Analyst Eric Handler said the recent pullback in shares and positive turnaround efforts provide a favorable risk/reward scenario. Handler said revenue stabilization has shifted to growth and new product initiatives should help drive 2017 revenue acceleration.
PEG PSEG
$41.49

0.59 (1.44%)

07/13/16
MSCO
07/13/16
UPGRADE
MSCO
Equal Weight
PSEG upgraded to Equal Weight from Underweight at Morgan Stanley
07/13/16
07/13/16
UPGRADE
Target $47

Equal Weight
PSEG upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley upgraded PSEG to Equal Weight from Underweight. Analyst Stephen Byrd expects stronger post-2017 earnings power based on the company's significant pipeline of regulated investment opportunities and the upcoming rate case to be filed in 2017. The analyst raised his price target to $47 from $43 and now sees modest upside to shares.
07/13/16
07/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pandora (P) upgraded to Overweight from Neutral at Piper Jaffray with analyst Stan Meyers saying the company is nearing an inflection point and that "meaningful upside" lies ahead. 2. Murphy Oil (MUR) upgraded to Overweight from Equal Weight at Barclays with analyst Paul Cheng saying the global oil market is currently in the "midst of a continued upward trajectory" in which Brent could average $85 by the fourth quarter of 2017 and $80-$90 between 2018 and 2021. 3. NuVasive (NUVA) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Hanover saying the company's first quarter outperformance "was not a fluke." 4. PSEG (PEG) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Stephen Byrd saying he expects stronger post-2017 earnings power based on the company's significant pipeline of regulated investment opportunities and the upcoming rate case to be filed in 2017. 5. Wright Medical (WMGI) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Hanover saying Wright over the past year has transformed into the only publicly traded orthopedics company with a revenue base of over $500M and a projected top-line growth rate north of 10%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/16
GSCO
10/16/16
UPGRADE
Target $47
GSCO
Buy
PSEG upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Michael Lapides upgraded PSEG to Buy saying the company's growth may surprise to the upside. The analyst is positive on the company's expected electric transmission and gas distribution earnings growth. He raised his price target for the shares to $47 from $46.

TODAY'S FREE FLY STORIES

AXS

AXIS Capital

$63.32

0.42 (0.67%)

08:31
12/09/16
12/09
08:31
12/09/16
08:31
Hot Stocks
AXIS Capital announces new $1B share repurchase authorization »

AXIS Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$43.22

0.51 (1.19%)

08:31
12/09/16
12/09
08:31
12/09/16
08:31
Hot Stocks
TD Ameritrade reports November client trades per day up 23% y/y »

TD Ameritrade announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$28.97

-0.83 (-2.79%)

, NTLA

Intellia Therapeutics

$15.38

0.06 (0.39%)

08:30
12/09/16
12/09
08:30
12/09/16
08:30
Options
Two new option listings and three option delistings on December 9th »

New option listings for…

ACRS

Aclaris Therapeutics

$28.97

-0.83 (-2.79%)

NTLA

Intellia Therapeutics

$15.38

0.06 (0.39%)

LGF

Lionsgate

$26.09

1.1 (4.40%)

LNKD

LinkedIn

STRZA

Starz

$35.52

0.59 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$12.33

-0.3 (-2.38%)

08:30
12/09/16
12/09
08:30
12/09/16
08:30
Conference/Events
Pure Storage participates in a conference call with UBS »

UBS IT Hardware & EMS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 12

    Jan

  • 13

    Jan

  • 09

    Dec

08:30
12/09/16
12/09
08:30
12/09/16
08:30
General news
U.S. equities are back in the green »

U.S. equities are back in…

SGYP

Synergy Pharmaceuticals

$5.54

0.06 (1.09%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Hot Stocks
Breaking Hot Stocks news story on Synergy Pharmaceuticals »

Synergy Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

LFUS

Littelfuse

$154.58

3.1 (2.05%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Littelfuse to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WWD

Woodward

$70.84

-0.26 (-0.37%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Wayfair Woodward to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DVAX

Dynavax

$4.80

-0.2 (-4.00%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Dynavax to host research and development day »

Cancer Research and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 15

    Dec

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

08:24
12/09/16
12/09
08:24
12/09/16
08:24
Downgrade
Duluth Holdings rating change  »

Duluth Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBAI

Lakeland Bancorp

$19.15

0.3 (1.59%)

08:24
12/09/16
12/09
08:24
12/09/16
08:24
Syndicate
Breaking Syndicate news story on Lakeland Bancorp »

Lakeland Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSD

Clearside Biomedical

$11.53

-2.9 (-20.10%)

08:23
12/09/16
12/09
08:23
12/09/16
08:23
Syndicate
Clearside Biomedical 4M share Secondary priced at $9.00 »

JPMorgan, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

BIIB

Biogen

$289.54

4.24 (1.49%)

, LLY

Eli Lilly

$67.19

-0.19 (-0.28%)

08:21
12/09/16
12/09
08:21
12/09/16
08:21
Recommendations
Biogen, Eli Lilly analyst commentary  »

Biogen has positive read…

BIIB

Biogen

$289.54

4.24 (1.49%)

LLY

Eli Lilly

$67.19

-0.19 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

08:20
12/09/16
12/09
08:20
12/09/16
08:20
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

FNSR

Finisar

$34.13

1.89 (5.86%)

08:17
12/09/16
12/09
08:17
12/09/16
08:17
Recommendations
Finisar analyst commentary  »

Finisar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBRA

Zebra Technologies

$83.39

0.47 (0.57%)

08:15
12/09/16
12/09
08:15
12/09/16
08:15
Recommendations
Zebra Technologies analyst commentary  »

Zebra Technologies prie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$170.71

2.16 (1.28%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Recommendations
Broadcom analyst commentary  »

Broadcom poised for above…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBJY

UCB Pharma

$30.84

-1.11 (-3.47%)

, MYL

Mylan

$36.06

1.56 (4.52%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Periodicals
UCB Pharma Vimpat patent 'thrown out' by patent office, Bronte Capital reports »

Argentum…

UCBJY

UCB Pharma

$30.84

-1.11 (-3.47%)

MYL

Mylan

$36.06

1.56 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

HLT

Hilton

$26.24

-0.8 (-2.96%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Downgrade
Hilton rating change  »

Hilton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CDEV

Centennial Resource Development

$18.29

-0.32 (-1.72%)

08:12
12/09/16
12/09
08:12
12/09/16
08:12
Initiation
Centennial Resource Development initiated  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTEA

Long Island Iced Tea

$4.91

0.2 (4.25%)

08:12
12/09/16
12/09
08:12
12/09/16
08:12
Hot Stocks
Long Island Iced Tea agrees to acquire ALO Juice »

Long Island Iced Tea…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCON

Superconductor Technologies

$2.02

-0.13 (-6.05%)

08:11
12/09/16
12/09
08:11
12/09/16
08:11
Syndicate
Superconductor Technologies raises $10.2M in a public offering »

The offering was priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMG

Cellular Biomedicine

$13.35

0.1 (0.75%)

08:09
12/09/16
12/09
08:09
12/09/16
08:09
Hot Stocks
Cellular Biomedicine announces 3-month interim safety data from AlloJoin trial »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EW

Edwards Lifesciences

$89.30

5.57 (6.65%)

08:09
12/09/16
12/09
08:09
12/09/16
08:09
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIRG

Airgain

$18.62

-2.13 (-10.27%)

08:08
12/09/16
12/09
08:08
12/09/16
08:08
Syndicate
Airgain 2.35M share Secondary priced at $17.00 »

Cowen, William Blair and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.